“But Dr. Old, we already have an antibody!” Reflections on Lloyd Old’s “academic biotech” approach for targeted antibodies

Cancer immunity

Gerd Ritter¹ 

[1] Ludwig Institute for Cancer Research, New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center, New York, NY, USALudwig Institute for Cancer Research, New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center, New York, NY, USALudwig Institute for Cancer Research, New York Branch of Human Cancer Immunology at Memorial Sloan-Kettering Cancer Center, New York, NY, USA

关键词: antibody therapy;    Ludwig Institute for Cancer Research;    Lloyd Old;   

DOI  :  

学科分类：肿瘤学

来源: Cancer immunity

【 授权许可】

Unknown